Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$242.49 - $301.46 $128,762 - $160,075
531 Added 4.25%
13,014 $3.15 Million
Q2 2022

Aug 10, 2022

BUY
$224.73 - $338.64 $22,697 - $34,202
101 Added 0.82%
12,483 $3.02 Million
Q1 2022

May 12, 2022

BUY
$277.25 - $366.29 $148,051 - $195,598
534 Added 4.51%
12,382 $4.1 Million
Q4 2021

Feb 10, 2022

BUY
$300.63 - $371.35 $122,957 - $151,882
409 Added 3.58%
11,848 $4.28 Million
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $459,081 - $556,776
1,480 Added 14.86%
11,439 $3.75 Million
Q2 2021

Aug 06, 2021

SELL
$262.71 - $351.17 $26,008 - $34,765
-99 Reduced 0.98%
9,959 $3.05 Million
Q1 2021

May 10, 2021

SELL
$285.92 - $355.13 $444,891 - $552,582
-1,556 Reduced 13.4%
10,058 $3.18 Million
Q4 2020

Feb 10, 2021

BUY
$251.88 - $324.2 $867,474 - $1.12 Million
3,444 Added 42.15%
11,614 $3.72 Million
Q3 2020

Nov 13, 2020

SELL
$255.22 - $317.0 $262,366 - $325,876
-1,028 Reduced 11.18%
8,170 $2.3 Million
Q2 2020

Aug 10, 2020

BUY
$141.4 - $257.09 $132,916 - $241,664
940 Added 11.38%
9,198 $2.18 Million
Q1 2020

May 21, 2020

BUY
$130.51 - $196.01 $1.08 Million - $1.62 Million
8,258 New
8,258 $1.15 Million
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $184,162 - $258,412
-1,156 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $9,849 - $15,636
56 Added 5.09%
1,156 $205,000
Q2 2019

Aug 13, 2019

BUY
$250.96 - $284.94 $7,779 - $8,833
31 Added 2.9%
1,100 $287,000
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $50,855 - $66,654
184 Added 20.79%
1,069 $306,000
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $301,317 - $476,236
-1,072 Reduced 54.78%
885 $287,000
Q3 2018

Nov 09, 2018

BUY
$354.53 - $449.75 $484,642 - $614,808
1,367 Added 231.69%
1,957 $871,000
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $164,061 - $263,263
590 New
590 $239,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.